NCT00605371 - Bioequivalence and Food Effect of 250mg of Lamotrigine XR | Biotech Hunter

Enrollment

209

Participants

Timeline

Start Date

January 15, 2008

Primary Completion Date

March 6, 2008

Study Completion Date

March 6, 2008

Conditions

Epilepsy

Interventions

DRUG

Lamotrigine tablet

Lamotrigine extended release single dose tablet will be available with dosing strengths of 200 milligrams and 50 milligrams intended to be administered orally in fasted state. It will be a round standard convex shape tablet.

DRUG

Lamotrigine caplet

Lamotrigine extended release single dose caplet will be available with dosing strength of 200 milligrams and 50 milligrams intended to be administered orally in fasted and fed state.

Trial Locations (1)

98418

GSK Investigational Site, Tacoma